Golden State Equity Partners’s Labcorp LH Stock Holding History

Golden State Equity Partners’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-73	Closed	-$19.5K	–	1125
2026 Q1	$19.5K	Buy	+73	New	+$19.8K	﹤0.01%	1102

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Golden State Equity Partners's LH Position: Q2 2026 in Review

Golden State Equity Partners sold out of Labcorp (LH) in Q2 2026, closing a stake of 73 shares — an estimated $19.5K sold.

Golden State Equity Partners first reported a position in LH in Q1 2026 and held it in 1 quarter. The position peaked at $19.5K in Q1 2026. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

Golden State Equity Partners reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
Golden State Equity Partners sold 73 Labcorp shares in Q2 2026, an estimated $19.5K.
Golden State Equity Partners first reported a position in Labcorp in Q1 2026 and held it in 1 quarter.
Golden State Equity Partners's Labcorp position peaked at $19.5K in Q1 2026.
1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Golden State Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.